JPWO2021154746A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021154746A5 JPWO2021154746A5 JP2022545827A JP2022545827A JPWO2021154746A5 JP WO2021154746 A5 JPWO2021154746 A5 JP WO2021154746A5 JP 2022545827 A JP2022545827 A JP 2022545827A JP 2022545827 A JP2022545827 A JP 2022545827A JP WO2021154746 A5 JPWO2021154746 A5 JP WO2021154746A5
- Authority
- JP
- Japan
- Prior art keywords
- itrs
- etrs
- radiation
- dose
- radiation dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000005855 radiation Effects 0.000 claims description 168
- 238000000034 method Methods 0.000 claims description 131
- 208000022914 Testicular regression syndrome Diseases 0.000 claims description 46
- 230000008685 targeting Effects 0.000 claims description 40
- 150000001875 compounds Chemical class 0.000 claims description 33
- 230000001186 cumulative effect Effects 0.000 claims description 32
- 238000001959 radiotherapy Methods 0.000 claims description 23
- 238000013507 mapping Methods 0.000 claims description 14
- 230000001225 therapeutic effect Effects 0.000 claims description 14
- 239000011159 matrix material Substances 0.000 claims description 12
- 230000002285 radioactive effect Effects 0.000 claims description 11
- -1 Cu-67 Chemical compound 0.000 claims description 7
- 238000003384 imaging method Methods 0.000 claims description 7
- 230000001988 toxicity Effects 0.000 claims description 5
- 231100000419 toxicity Toxicity 0.000 claims description 5
- 238000004364 calculation method Methods 0.000 claims description 4
- 238000010304 firing Methods 0.000 claims description 4
- 238000013527 convolutional neural network Methods 0.000 claims description 2
- 239000000700 radioactive tracer Substances 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 102000023732 binding proteins Human genes 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 238000002603 single-photon emission computed tomography Methods 0.000 description 3
- PDWUPXJEEYOOTR-UHFFFAOYSA-N 2-[(3-iodophenyl)methyl]guanidine Chemical compound NC(=N)NCC1=CC=CC(I)=C1 PDWUPXJEEYOOTR-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- OBBCSXFCDPPXOL-UHFFFAOYSA-N misonidazole Chemical compound COCC(O)CN1C=CN=C1[N+]([O-])=O OBBCSXFCDPPXOL-UHFFFAOYSA-N 0.000 description 2
- 229950010514 misonidazole Drugs 0.000 description 2
- GEPYEWPQCQPUJN-JWXFUTCRSA-N (2r,3s,4s,5s)-2-(hydroxymethyl)-5-(2-nitroimidazol-1-yl)oxolane-3,4-diol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]1N1C([N+]([O-])=O)=NC=C1 GEPYEWPQCQPUJN-JWXFUTCRSA-N 0.000 description 1
- OLWVRJUNLXQDSP-RYUDHWBXSA-N (2s)-2-[[(1s)-1-carboxy-5-[(6-fluoropyridine-3-carbonyl)amino]pentyl]carbamoylamino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)N[C@H](C(O)=O)CCCCNC(=O)C1=CC=C(F)N=C1 OLWVRJUNLXQDSP-RYUDHWBXSA-N 0.000 description 1
- QJUIUFGOTBRHKP-LQJZCPKCSA-N (2s)-2-[[(1s)-1-carboxy-5-[6-[3-[3-[[2-[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]methyl]-4-hydroxyphenyl]propanoylamino]hexanoylamino]pentyl]carbamoylamino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)N[C@H](C(O)=O)CCCCNC(=O)CCCCCNC(=O)CCC1=CC=C(O)C(CN(CCN(CC(O)=O)CC=2C(=CC=C(CCC(O)=O)C=2)O)CC(O)=O)=C1 QJUIUFGOTBRHKP-LQJZCPKCSA-N 0.000 description 1
- QVFLVLMYXXNJDT-CSBVGUNJSA-N (2s,3r)-2-[[(4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-7-[(1r)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[(2r)-3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]pro Chemical compound C([C@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC1=O)C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)C1=CC=CC=C1 QVFLVLMYXXNJDT-CSBVGUNJSA-N 0.000 description 1
- OSUJVKAXNLHVRB-HUMWUIFSSA-N 2-[4,7-bis(carboxymethyl)-10-[2-[[4-[3-[(2r,5s,8s,14r)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propylcarbamoyl]phenyl]methylamino]-2-o Chemical compound C([C@H]1N(C([C@@H](CC=2C=CC(O)=CC=2)NC(=O)CNC(=O)[C@H](CC=2C=C3C=CC=CC3=CC=2)NC(=O)[C@H](CCCN=C(N)N)NC1=O)=O)C)CCNC(=O)C(C=C1)=CC=C1CNC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 OSUJVKAXNLHVRB-HUMWUIFSSA-N 0.000 description 1
- RZHKDBRREKOZEW-AAXZNHDCSA-N 2-[4-[2-[[(2r)-1-[[(4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-4-[[(2r,3r)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1r)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl] Chemical compound C([C@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)NC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)C1=CC=CC=C1 RZHKDBRREKOZEW-AAXZNHDCSA-N 0.000 description 1
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 1
- 108010001692 68Ga-pentixafor Proteins 0.000 description 1
- 108010074708 B7-H1 Antigen Proteins 0.000 description 1
- 102100032412 Basigin Human genes 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108700038672 Edotreotide Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108010037516 PSMA-617 Proteins 0.000 description 1
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 1
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
- 102100040678 Programmed cell death protein 1 Human genes 0.000 description 1
- 101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 229940010982 dotatate Drugs 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 238000011347 external beam therapy Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960003795 iobenguane (123i) Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- IDTMSHGCAZPVLC-RYUDHWBXSA-N n-({(1r)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-l-glutamic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)N[C@H](C(O)=O)CSCC1=CC=C(F)C=C1 IDTMSHGCAZPVLC-RYUDHWBXSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229960005267 tositumomab Drugs 0.000 description 1
- 229960000575 trastuzumab Drugs 0.000 description 1
- JBHPLHATEXGMQR-LFWIOBPJSA-N vipivotide tetraxetan Chemical compound OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)[C@H](CC1=CC=C2C=CC=CC2=C1)NC(=O)[C@H]1CC[C@H](CNC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)CC1)C(O)=O)C(O)=O JBHPLHATEXGMQR-LFWIOBPJSA-N 0.000 description 1
Images
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2024034601A JP2024053037A (ja) | 2020-01-28 | 2024-03-07 | 放射性核種および外部ビーム放射線療法の共同最適化 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062966997P | 2020-01-28 | 2020-01-28 | |
US62/966,997 | 2020-01-28 | ||
PCT/US2021/015119 WO2021154746A1 (en) | 2020-01-28 | 2021-01-26 | Joint optimization of radionuclide and external beam radiotherapy |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024034601A Division JP2024053037A (ja) | 2020-01-28 | 2024-03-07 | 放射性核種および外部ビーム放射線療法の共同最適化 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023512214A JP2023512214A (ja) | 2023-03-24 |
JPWO2021154746A5 true JPWO2021154746A5 (de) | 2024-02-05 |
Family
ID=74672434
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022545827A Pending JP2023512214A (ja) | 2020-01-28 | 2021-01-26 | 放射性核種および外部ビーム放射線療法の共同最適化 |
JP2024034601A Pending JP2024053037A (ja) | 2020-01-28 | 2024-03-07 | 放射性核種および外部ビーム放射線療法の共同最適化 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024034601A Pending JP2024053037A (ja) | 2020-01-28 | 2024-03-07 | 放射性核種および外部ビーム放射線療法の共同最適化 |
Country Status (7)
Country | Link |
---|---|
US (2) | US11654300B2 (de) |
EP (1) | EP4096781A1 (de) |
JP (2) | JP2023512214A (de) |
CN (1) | CN115279456A (de) |
AU (1) | AU2021212659A1 (de) |
CA (1) | CA3169406A1 (de) |
WO (1) | WO2021154746A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11537912B2 (en) * | 2020-02-19 | 2022-12-27 | Varian Medical Systems International Ag | Generating and applying robust dose prediction models |
US20230001233A1 (en) * | 2021-06-30 | 2023-01-05 | Varian Medical Systems Particle Therapy GmbH & Co, KG | Analysis of dose rate robustness against uncertainties in radiation treatment planning |
CA3235735A1 (en) * | 2021-09-25 | 2023-03-30 | Michael Bortz | Mco planning of treatments with available technologies in radiotherapy (rt) |
US20230125812A1 (en) * | 2021-10-22 | 2023-04-27 | Viewray Technologies, Inc. | Systems, methods and computer software for optimized radiation therapy |
WO2023086588A1 (en) * | 2021-11-11 | 2023-05-19 | Mim Software Inc. | Base dose calculation |
US11904186B2 (en) * | 2022-01-12 | 2024-02-20 | Capital Medical University | Radiotherapeutical or radiosurgical system comprising two or more rotatable high-intensity radiation sources and a ring-shaped imager, and methods thereof |
EP4311573A1 (de) * | 2022-07-28 | 2024-01-31 | Siemens Healthcare GmbH | Verfahren und system zur bestimmung einer behandlungsfortsetzungsinformation für eine strahlentherapie |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4932412A (en) | 1986-12-18 | 1990-06-12 | Immunomedics, Inc. | Intraoperative and endoscopic tumor detection and therapy |
US5647663A (en) | 1996-01-05 | 1997-07-15 | Wisconsin Alumni Research Foundation | Radiation treatment planning method and apparatus |
US6187037B1 (en) * | 1998-03-11 | 2001-02-13 | Stanley Satz | Metal stent containing radioactivatable isotope and method of making same |
ATE374640T1 (de) | 1998-08-06 | 2007-10-15 | Wisconsin Alumni Res Found | Prüfsystem für radiotherapie |
AU757570B2 (en) | 1998-08-06 | 2003-02-27 | Wisconsin Alumni Research Foundation | Method for preparing a radiation therapy plan |
US6402689B1 (en) | 1998-09-30 | 2002-06-11 | Sicel Technologies, Inc. | Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors |
CA2371728C (en) | 1999-06-11 | 2009-06-02 | Neorx Corporation | High dose radionuclide complexes for bone marrow suppression |
US6911200B2 (en) | 2000-03-24 | 2005-06-28 | Cell Genesys, Inc. | Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation |
WO2002024278A1 (en) | 2000-09-22 | 2002-03-28 | Numerix Llc | Improved radiation therapy treatment method |
US9320813B2 (en) | 2002-02-14 | 2016-04-26 | Gholam A. Peyman | Method and composition for hyperthermally treating cells |
EP1501489A4 (de) | 2002-04-15 | 2007-11-21 | Sloan Kettering Inst Cancer | Kombinationstherapie zur behandlung von krebs |
US7289599B2 (en) | 2002-10-04 | 2007-10-30 | Varian Medical Systems Technologies, Inc. | Radiation process and apparatus |
US7651689B2 (en) | 2002-11-15 | 2010-01-26 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of applying ionization radiation for therapy of infections |
US7945021B2 (en) | 2002-12-18 | 2011-05-17 | Varian Medical Systems, Inc. | Multi-mode cone beam CT radiotherapy simulator and treatment machine with a flat panel imager |
US20050143965A1 (en) | 2003-03-14 | 2005-06-30 | Failla Gregory A. | Deterministic computation of radiation doses delivered to tissues and organs of a living organism |
US20060228297A1 (en) | 2003-04-15 | 2006-10-12 | Roy Larsen | Thorium-227 for use in radiotherapy of soft tissue disease |
DE602004024682D1 (de) | 2003-07-15 | 2010-01-28 | Koninkl Philips Electronics Nv | Ung |
US20050027196A1 (en) | 2003-07-30 | 2005-02-03 | Fitzgerald Loretta A. | System for processing patient radiation treatment data |
US20050196340A1 (en) | 2003-08-06 | 2005-09-08 | Jocelyn Holash | Use of a VEGF antagonist in combination with radiation therapy |
DE602004025726D1 (de) | 2003-11-14 | 2010-04-08 | Genvec Inc | Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc). |
WO2005072825A1 (en) | 2004-01-20 | 2005-08-11 | University Of Florida Research Foundation, Inc. | Radiation therapy system using interior-point methods and convex models for intensity modulated fluence map optimization |
CA2556934C (en) | 2004-02-20 | 2018-05-22 | James F. Dempsey | System for delivering conformal radiation therapy while simultaneously imaging soft tissue |
US20070275934A1 (en) | 2004-05-10 | 2007-11-29 | Curd John G | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments |
WO2006012355A2 (en) | 2004-06-28 | 2006-02-02 | University Of Maryland, Baltimore | Radiolabeled nanohybrids targeting solid tumor neovasculature and method of using same |
US8423125B2 (en) | 2004-11-09 | 2013-04-16 | Spectrum Dynamics Llc | Radioimaging |
DE102005007851A1 (de) | 2005-02-21 | 2006-08-24 | Siemens Ag | Bestrahlungsvorrichtung |
US20060257317A1 (en) | 2005-05-04 | 2006-11-16 | Duke University | Combination therapy in the treatment of cancer |
US7875602B2 (en) | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
RU2446843C2 (ru) | 2006-08-01 | 2012-04-10 | Конинклейке Филипс Электроникс, Н.В. | Планирование биологически направляемой адаптивной терапии |
WO2008130380A2 (en) | 2006-10-25 | 2008-10-30 | Bruce Reiner | Method and apparatus of providing a radiation scorecard |
TW200833345A (en) | 2006-11-01 | 2008-08-16 | Novacea Inc | Use of vitamin D compounds and mimics thereof to enhance delivery of therapeutics and oxygen to tumors and other tissues |
US9387344B2 (en) | 2006-11-21 | 2016-07-12 | The Johns Hopkins University | Methods for determining absorbed dose information |
US8663083B2 (en) | 2006-12-08 | 2014-03-04 | Koninklijke Philips N.V. | System, method, computer-readable medium, and use for planning combined therapy |
WO2008120116A1 (en) | 2007-03-30 | 2008-10-09 | Koninklijke Philips Electronics N.V. | Improved treatment plan evaluation in radiotherapy by stochastic analysis of delineation uncertainty |
JP5331116B2 (ja) | 2007-07-30 | 2013-10-30 | ローマ リンダ ユニヴァーシティ メディカル センター | 粒子放射線で増強された治療を供給するシステム及び方法 |
US8784846B2 (en) | 2007-07-30 | 2014-07-22 | Loma Linda University Medical Center | Systems and methods for particle radiation enhanced delivery of therapy |
DE102007039454B4 (de) | 2007-08-21 | 2016-07-28 | Siemens Healthcare Gmbh | Verfahren zur Quantifizierung der Aufnahme wenigstens eines Radiotracers in einem für eine Positronen-Emissions-Tomograpie-Messung interessierenden Körperbereich eines Patienten |
EP2201490A2 (de) | 2007-09-04 | 2010-06-30 | Koninklijke Philips Electronics N.V. | Vorrichtung und verfahren zur planung mehrerer behandlungen |
US8017915B2 (en) | 2008-03-14 | 2011-09-13 | Reflexion Medical, Inc. | Method and apparatus for emission guided radiation therapy |
US20110086850A1 (en) | 2008-04-11 | 2011-04-14 | Board Of Regents, The University Of Texas System | Radiosensitization of tumors with indazolpyrrolotriazines for radiotherapy |
US9387342B2 (en) | 2008-07-21 | 2016-07-12 | Varian Medical Systems, Inc. | External beam radiotherapy and imaging with radioactive isotope |
WO2010018477A2 (en) | 2008-08-15 | 2010-02-18 | Koninklijke Philips Electronics N.V. | Model enhanced imaging |
US7817778B2 (en) | 2008-08-29 | 2010-10-19 | Varian Medical Systems International Ag | Interactive treatment plan optimization for radiation therapy |
US10363437B2 (en) | 2008-12-11 | 2019-07-30 | Varian Medical Systems International Ag | Real time treatment parameter algorithm for moving targets |
US20100178244A1 (en) | 2009-01-13 | 2010-07-15 | Arnsdorf Morton F | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
US20100178245A1 (en) | 2009-01-13 | 2010-07-15 | Arnsdorf Morton F | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
EP2412405B1 (de) | 2009-03-24 | 2015-05-20 | National University Corporation Hokkaido University | Gerät für strahlentherapie |
US8693629B2 (en) * | 2009-12-09 | 2014-04-08 | The Johns Hopkins University | Method and system for administering internal radionuclide therapy (IRT) and external radiation therapy (XRT) |
US9757084B2 (en) | 2011-12-22 | 2017-09-12 | The Johns Hopkins University | Method and system for administering radiopharmaceutical therapy (RPT) |
US10007961B2 (en) | 2009-09-09 | 2018-06-26 | Wisconsin Alumni Research Foundation | Treatment planning system for radiopharmaceuticals |
WO2011053802A2 (en) | 2009-10-30 | 2011-05-05 | Tomotherapy Incorporated | Non-voxel-based broad-beam (nvbb) algorithm for intensity modulated radiation therapy dose calculation and plan optimization |
CN102812045B (zh) | 2009-11-13 | 2018-04-13 | 第一三共欧洲有限公司 | 用于治疗或预防人表皮生长因子受体‑3(her‑3)相关疾病的材料和方法 |
JP5595738B2 (ja) | 2010-01-05 | 2014-09-24 | 株式会社東芝 | 核医学診断装置 |
US20120323599A1 (en) | 2010-03-08 | 2012-12-20 | Koninklijke Philips Electronics N.V. | Scheduling of dose calculation tasks including efficient dose calculation |
CN102068763B (zh) | 2010-03-23 | 2013-03-27 | 北京大基康明医疗设备有限公司 | 放射处理的验证方法和放射处理装置 |
JP5714438B2 (ja) | 2010-07-15 | 2015-05-07 | 株式会社東芝 | 放射線治療システム及びその作動方法 |
US20120029396A1 (en) | 2010-07-29 | 2012-02-02 | Kobi Vortman | Motion compensation for non-invasive treatment therapies |
US9028499B2 (en) | 2011-02-23 | 2015-05-12 | The Regents Of The University Of California | Bone cutting device |
US11478568B2 (en) | 2011-02-23 | 2022-10-25 | The Regents Of The University Of California | Radioactive cement |
BR112013023264A2 (pt) | 2011-03-15 | 2018-07-03 | Koninklijke Philips Nv | sistema de planejamento de tratamento para a geração de margens de tratamento específico do paciente, método e sistema de terapia por radiação. |
CN110585607B (zh) | 2011-03-31 | 2022-07-19 | 反射医疗公司 | 用于在发射引导的放射治疗中使用的系统和方法 |
US9180214B1 (en) | 2011-04-22 | 2015-11-10 | Stc.Unm | Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer |
US20120292534A1 (en) | 2011-05-20 | 2012-11-22 | Sarah Geneser | Multi-phase Gating for Radiation Treatment Delivery and Imaging |
EP2745850B1 (de) | 2011-09-16 | 2018-05-16 | Shimadzu Corporation | Nanopartikel zur internen strahlentherapie eines betroffenen bereichs und therapiesystem |
US8836697B2 (en) | 2011-09-30 | 2014-09-16 | Varian Medical Systems International Ag | Real-time 3D dose visualization system |
CN103945901A (zh) | 2011-10-14 | 2014-07-23 | 住友重机械工业株式会社 | 带电粒子束照射系统以及带电粒子束照射计划方法 |
US9314160B2 (en) | 2011-12-01 | 2016-04-19 | Varian Medical Systems, Inc. | Systems and methods for real-time target validation for image-guided radiation therapy |
KR102006599B1 (ko) | 2011-12-21 | 2019-08-01 | 아이소테라퓨틱스 그룹 엘엘씨 | 방사성 조성물 및 그의 치료적 사용 방법 |
WO2013093852A1 (de) | 2011-12-23 | 2013-06-27 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Navigierbare darstellung einer losungsvielfalt von therapieplanen |
EP2664359A1 (de) | 2012-05-14 | 2013-11-20 | Koninklijke Philips N.V. | Magnetresonanzgeführte Therapie mit überlapptem Abtasten |
JP2014023741A (ja) | 2012-07-27 | 2014-02-06 | Univ Of Tokushima | 強度変調放射線治療計画装置、強度変調放射線照射装置の放射線ビーム係数演算方法、強度変調放射線治療計画プログラム及びコンピュータで読み取り可能な記録媒体並びに記録した機器 |
FR2996008B1 (fr) | 2012-09-26 | 2016-08-19 | Univ Rennes | Procede d'evaluation d'une methode de determination de la dose cumulee recue au cours d'un traitement de radiotherapie |
CN103845068A (zh) | 2012-11-28 | 2014-06-11 | 北京大基康明医疗设备有限公司 | 融合pet-ct功能的高能放射治疗系统 |
PL2900277T3 (pl) | 2012-12-13 | 2022-05-16 | Immunomedics, Inc. | Dawkowanie immunokoniugatów przeciwciał i sn-38 dla poprawy skuteczności i zmniejszenia toksyczności |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
JP2014166245A (ja) | 2013-02-28 | 2014-09-11 | Mitsubishi Heavy Ind Ltd | 治療計画装置、計画治療システム、治療計画生成方法およびプログラム |
US9504850B2 (en) | 2013-03-14 | 2016-11-29 | Xcision Medical Systems Llc | Methods and system for breathing-synchronized, target-tracking radiation therapy |
US20140343344A1 (en) | 2013-04-08 | 2014-11-20 | Cubresa Inc. | Radiation Therapy Guided Using Gamma Imaging |
US9839704B2 (en) | 2013-05-02 | 2017-12-12 | Duke University | Prosthetic compounds for labeling internalizing biomolecules |
EP3048977B1 (de) | 2013-09-25 | 2018-12-26 | Black, Richard R. | Patientenspezifische analyse von positronenemissionstomografiedaten |
WO2015044239A1 (en) * | 2013-09-30 | 2015-04-02 | Koninklijke Philips N.V. | Medical instrument for external beam radiotherapy and brachytherapy |
JP6208535B2 (ja) | 2013-10-25 | 2017-10-04 | 株式会社日立製作所 | 放射線治療装置およびシステムおよび方法 |
WO2015153991A1 (en) | 2014-04-04 | 2015-10-08 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Radiotherapy targeted to promote a systemic abscopal effect |
WO2015168431A1 (en) | 2014-04-30 | 2015-11-05 | Stc.Unm | Optimization methods for radiation therapy planning |
EP3146364A4 (de) | 2014-05-23 | 2018-01-24 | Brigham and Women's Hospital, Inc. | Detektoren, system und verfahren zur detektion von ionisierender strahlung mittels eines hochenergetischen stroms |
US9956428B2 (en) | 2014-07-18 | 2018-05-01 | Generations International Asset Management Company Llc | Radiosurgical planning and treatment |
US9782607B2 (en) | 2014-08-05 | 2017-10-10 | The University Of Chicago | Systems and methods for radiation treatment planning using combined imaging and treatment dose |
US10537749B2 (en) | 2014-08-15 | 2020-01-21 | Koninklijke Philips N.V. | Supervised 4-D dose map deformation for adaptive radiotherapy planning |
WO2016064750A1 (en) | 2014-10-20 | 2016-04-28 | New York University | Method to select radiation dosage for tumor treatment based on cellular imaging |
US20160256713A1 (en) | 2015-02-11 | 2016-09-08 | Cubresa Inc. | Radiation Therapy Guided Using PET Imaging |
JP2016168077A (ja) | 2015-03-11 | 2016-09-23 | 三菱電機株式会社 | 治療計画装置 |
US9925283B2 (en) * | 2015-04-10 | 2018-03-27 | Wisconsin Alumni Research Foundation | Alkylphosphocholine analogs for multiple myeloma imaging and therapy |
WO2016201348A1 (en) | 2015-06-10 | 2016-12-15 | Reflexion Medical, Inc. | High bandwidth binary multi-leaf collimator design |
US10328282B2 (en) | 2015-07-13 | 2019-06-25 | Mayo Foundation For Medical Education And Research | System and method for novel chance-constrained optimization in intensity-modulated proton therapy planning to account for range and patient setup uncertainties |
US9884206B2 (en) | 2015-07-23 | 2018-02-06 | Loma Linda University Medical Center | Systems and methods for intensity modulated radiation therapy |
US10702708B2 (en) | 2015-09-25 | 2020-07-07 | Varian Medical Systems, Inc. | Accounting for imaging-based radiation doses |
RU2753677C2 (ru) | 2015-10-05 | 2021-08-19 | Фредакс Аб | Полипептиды антител и их применение |
US20190046813A1 (en) | 2016-02-02 | 2019-02-14 | Suzhou Evidance Medical Technologies Inc. | Systems and Methods for Radiation Treatment Planning |
CN109152928B (zh) | 2016-03-09 | 2021-05-28 | 反射医疗公司 | 用于计算辐射治疗的注量图的方法和系统 |
JP2019513826A (ja) | 2016-04-06 | 2019-05-30 | ノクソファーム リミティド | 放射線療法の改善 |
TWI755395B (zh) | 2016-05-13 | 2022-02-21 | 美商再生元醫藥公司 | 抗-pd-1抗體與輻射治療癌症之組合 |
EP3484513B1 (de) | 2016-07-18 | 2023-06-07 | Wisconsin Alumni Research Foundation | Radiohalogenierte agenten für kombinierte krebstherapie |
US11633506B2 (en) | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
WO2018022571A1 (en) | 2016-07-25 | 2018-02-01 | Wisconsin Alumni Research Foundation | Targeted radiotherapy chelates for in situ immune modulated cancer vaccination |
EP3504348B1 (de) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Verwendung von genomischen signaturen zur vorhersage des ansprechens von patienten mit prostatakrebs auf postoperative strahlentherapie |
CA3076903A1 (en) * | 2016-09-23 | 2018-03-29 | The Royal Institution For The Advancement Of Learning/Mcgill University | Treatment planning based on multiple modalities |
EP3541281B1 (de) | 2016-11-15 | 2021-09-08 | RefleXion Medical, Inc. | System zur emissionsgeführten abgabe von photonen |
CA3054248A1 (en) | 2017-02-24 | 2018-08-30 | Bayer As | Combination therapy comprising a radiopharmaceutical and a dna-repair inhibitor |
CN110997063B (zh) | 2017-05-30 | 2022-04-29 | 反射医疗公司 | 用于计算放射注量的方法的放射治疗系统 |
JP2020525093A (ja) * | 2017-06-22 | 2020-08-27 | リフレクション メディカル, インコーポレイテッド | 生物学的適合放射線療法のためのシステムおよび方法 |
EP3424533A1 (de) | 2017-07-05 | 2019-01-09 | Nh Theraguix | Verfahren zur behandlung von tumoren |
CN117761751A (zh) * | 2017-07-26 | 2024-03-26 | 反射医疗公司 | 放射治疗的图形表示 |
JP2021502368A (ja) | 2017-11-10 | 2021-01-28 | ウイスコンシン アラムナイ リサーチ ファウンデーシヨンWisconsin Alumni Research Foundation | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法(trt)の使用 |
TWI675669B (zh) | 2018-03-05 | 2019-11-01 | 白金科技股份有限公司 | 放射微球及其製備方法 |
EP3539616A1 (de) | 2018-03-13 | 2019-09-18 | Koninklijke Philips N.V. | Optimierung von fraktionierungsschemata in der strahlentherapie mittels berechnung biologischer auswirkungen |
EP3790454A4 (de) | 2018-05-10 | 2022-03-02 | University of Washington | Personalisiertes heimdosimetrie-kleidungsstück mit mehreren detektoren |
-
2021
- 2021-01-26 JP JP2022545827A patent/JP2023512214A/ja active Pending
- 2021-01-26 US US17/158,848 patent/US11654300B2/en active Active
- 2021-01-26 CN CN202180021554.8A patent/CN115279456A/zh active Pending
- 2021-01-26 EP EP21707084.6A patent/EP4096781A1/de active Pending
- 2021-01-26 AU AU2021212659A patent/AU2021212659A1/en active Pending
- 2021-01-26 CA CA3169406A patent/CA3169406A1/en active Pending
- 2021-01-26 WO PCT/US2021/015119 patent/WO2021154746A1/en unknown
-
2023
- 2023-04-14 US US18/301,085 patent/US20230405359A1/en active Pending
-
2024
- 2024-03-07 JP JP2024034601A patent/JP2024053037A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lassmann et al. | Dosimetry of 223 Ra-chloride: dose to normal organs and tissues | |
Funk et al. | Radiation dose estimate in small animal SPECT and PET | |
JP2023512214A (ja) | 放射性核種および外部ビーム放射線療法の共同最適化 | |
Sgouros et al. | Dosimetry for radiopharmaceutical therapy | |
US9387344B2 (en) | Methods for determining absorbed dose information | |
Gupta et al. | Dosimetric analyses of kidneys, liver, spleen, pituitary gland, and neuroendocrine tumors of patients treated with 177Lu-DOTATATE | |
US20110060602A1 (en) | Treatment Planning System For Radiopharmaceuticals | |
Svensson et al. | Nephrotoxicity profiles and threshold dose values for [177Lu]-DOTATATE in nude mice | |
Ling et al. | Preclinical dosimetry, imaging, and targeted radionuclide therapy studies of Lu-177-labeled albumin-binding, PSMA-targeted CTT1403 | |
Howard et al. | Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations | |
Yousefnia et al. | Preliminary dosimetric evaluation of 166Ho-TTHMP for human based on biodistribution data in rats | |
EP0827411B1 (de) | Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten | |
George et al. | Developments in 177Lu-based radiopharmaceutical therapy and dosimetry | |
Moawad | Isolated system towards a successful radiotherapy treatment | |
JPWO2021154746A5 (de) | ||
Tylski et al. | Tissue dose estimation after extravasation of 177 Lu-DOTATATE | |
Baum et al. | Systemic endoradiotherapy with carrier-added 4-[131 I] Iodo-L-phenylalanine: clinical proof-of-principle in refractory glioma | |
Argyrou et al. | Patient specific dosimetric calculations obtained by planar images and Monte Carlo simulation in 111In octreotide therapy | |
Kalantzis et al. | A computational tool for patient specific dosimetry and radiobiological modeling of selective internal radiation therapy with 90Y microspheres | |
Roberson | Dose Response Modeling for Targeted Radiotherapies | |
Stabin | Radiotherapy with internal emitters: What can dosimetrists offer? | |
Glatting | Radiation Dosimetry in Ibritumomab Therapy | |
Soliman et al. | Recent Advances in Biodistribution, Preclinical and Clinical Applications of Radiolabelled Iodine | |
Salvatori et al. | Principles of Radiation Biology and Dosimetry for Nuclear Medicine Procedures | |
Feray | CURRENT NUCLEAR MEDICINE THERANOSTIC APPROACHES TO NEUROENDOCRINE TUMORS |